Výsledky vyhledávání - "Fausto Tuccia"

Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer

Autor: Stefania Gori, Giulia Russo, Andrea Di Lenarda, Giovanni Cioffi, Daniella Bovelli, Gianfranco Alunni, Fausto Tuccia, Giuseppe Di Tano, Pompilio Faggiano, Luigi Tarantini

Publikováno v: Internal and Emergency Medicine. 7:439-446

Anthracyclines, taxanes and trastuzumab are used for therapy in early breast cancer (EBC) overexpressing Human Epidermal Growth Factor 2 (HER2+). These drugs, considered alone, do not present potential nephrotoxicity. However, renal dysfunction (RD)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f60b96844592b451f2a583620423a81
https://doi.org/10.1007/s11739-012-0794-9

Zobrazit plný text záznamu

Clinical Governance Benchmarking Issues in Oncology: Aggressiveness of Cancer Care and Consumption of Strong Opioids. A Single-Center Experience on Measurement of Quality of Care

Autor: Annarita Quarta, Marilisa Marcante, Petros Giovanis, Viviana Lovat, Fausto Tuccia, Francesca Caldart, Laura Moretto, Antonella Garna, Giovanni De Leonardis, Mauro Giusto

Publikováno v: Tumori Journal. 96:443-447

Aims and background The aggressiveness of cancer care near the end of life and the consumption of opioids are potential indicators of quality of care in palliative and end-of-life settings. The purpose of this article is to present a retrospective an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5537cd0e8299b3a5dd7822159a050f6c
https://doi.org/10.1177/030089161009600311

Zobrazit plný text záznamu

Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab adjuvant chemotherapy for early breast cancer

Autor: Fausto Tuccia, Giovanni Cioffi, Carmen Pacilio, Luigi Tarantini, Michelino De Laurentiis, Giulia Russo, Immacolata Capasso, Stefano Oliva, Stefania Gori, Clemente Cipresso, Carmela Coppola, Rosario Vincenz Iaffaioli, Giovanna Piscopo, Nicola Maurea

Publikováno v: Journal of Clinical Oncology. 31:e11556-e11556

e11556 Background: Adjuvant trastuzumab therapy improves survival of Human Epidermal growth factor Receptor 2 (HER2)-positive women with early breast cancer (EBC). Trastuzumab-induced cardiotoxicity is not uncommon, occurring prevalently asymptomatic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ffc02f183fbe5fd596270721203a67a6
https://doi.org/10.1200/jco.2013.31.15_suppl.e11556

Zobrazit plný text záznamu

Liposome-encapsulated doxorubicin plus cyclophosphamide followed by trastuzumab plus docetaxel as neoadjuvant therapy for HER2-positive breast cancer (BC): A multicenter single-arm phase II study

Autor: Manuela Bertola, Alessandro Del Conte, Fausto Tuccia, Tania Baresic, Salvatore Tumolo, Anna Bassini, Elvia Micheli, Giuseppina Gusso, Stefania Manente, Luisa Foltran, Silvana Saracchini, Sandro Sulfaro

Publikováno v: Publons

641 Background: Trastuzumab combined to sequential chemotherapy with taxanes and anthracyclines as primary treatment achieved high rates of pathologic complete response (pCR) in HER2 positive BC. Liposome-encapsulated doxorubicin (DLNP) shown equal e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b335047d7ff04444235e70cd516ce735
https://doi.org/10.1200/jco.2013.31.15_suppl.641

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání